Comparative Benefits and Risks Associated with Currently Authorized COVID-19 Vaccines

This article provides a systematic assessment of the efficacy, risks, and methodological quality of evidence from five major publicly available vaccine trials. Results from Pfizer-BioNTech mRNA, Moderna-US NIH mRN-1273, AstraZeneca-Oxford ChAdOx1 nCov-19, Gamaleya GamCovidVac (Sputnik V), and Ad26.C...

Descripción completa

Detalles Bibliográficos
Autores principales: Albers, Jacob R., Brown, Jeffrey B., Charkowick, Shaun V., Ram, Natasha, Klocksieben, Farina A., Kumar, Ambuj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788423/
https://www.ncbi.nlm.nih.gov/pubmed/36560476
http://dx.doi.org/10.3390/vaccines10122065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788423/
https://www.ncbi.nlm.nih.gov/pubmed/36560476
http://dx.doi.org/10.3390/vaccines10122065

Ejemplares similares